Science ❯ Virology

COVID-19 Variants

Vaccine Development Vaccine Efficacy Vaccines Vaccination Infectious Disease Characteristics BA.2.86 Variant Vaccination Development Genomic Sequencing Testing Methods Transmission LF.7

FDA Advisers Recommend XFG as Target for 2026–2027 COVID-19 Vaccines

The recommendation steers fall vaccine production toward XFG to boost protection against the currently dominant JN.1-family strains.

Stratus Variant Drives California COVID Wave as FDA Limits New Vaccine to High-Risk Patients